Dexamethasone/levofloxacin
Jump to navigation
Jump to search
Combination of | |
---|---|
Dexamethasone | Corticosteroid |
Levofloxacin | Anti-infective |
Clinical data | |
Trade names | Levodexa |
Routes of administration | Eye drops |
ATC code | |
Legal status | |
Legal status |
Dexamethasone/levofloxacin, sold under the brand name Levodexa, is a fixed-dose combination medication used for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery.[1] It contains dexamethasone, a corticosteroid; and levofloxacin, an anti-infective.[1]
It was approved for medical use in Canada in December 2023.[1]
Medical uses
Dexamethasone/levofloxacin is indicated for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery in adults.[1]
References
- ^ a b c d e "Regulatory Decision Summary for Levodexa". Drug and Health Products Portal. 12 December 2023. Retrieved 2 April 2024.
- ^ "Levodexa Product information". Health Canada. 12 December 2023. Retrieved 2 April 2024.
Categories:
- Articles with short description
- Short description is different from Wikidata
- Use American English from April 2024
- All Wikipedia articles written in American English
- Use dmy dates from April 2024
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Combination drugs
- Ophthalmology drugs
- All stub articles
- Pharmacology stubs